iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Sees Significant Drop in Short Interest

Posted by Stacy Sanders on Jul 12th, 2026

iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN – Get Free Report) saw a significant decrease in short interest in the month of June. As of June 30th, there was short interest totaling 3,425 shares, a decrease of 73.6% from the June 15th total of 12,988 shares. Approximately 2.3% of the company’s stock are sold short. Based on an average daily volume of 4,287 shares, the short-interest ratio is currently 0.8 days.

iShares Neuroscience and Healthcare ETF Trading Down 3.1%

iShares Neuroscience and Healthcare ETF stock traded down $1.24 on Friday, hitting $39.05. 6,859 shares of the stock traded hands, compared to its average volume of 2,129. The firm has a market cap of $5.86 million, a P/E ratio of 15.61 and a beta of 0.73. The business’s fifty day simple moving average is $36.08 and its 200 day simple moving average is $33.80. iShares Neuroscience and Healthcare ETF has a 1 year low of $22.41 and a 1 year high of $40.42.

About iShares Neuroscience and Healthcare ETF

(Get Free Report)

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.